Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis
K Sandhoff, K Harzer - Journal of Neuroscience, 2013 - Soc Neuroscience
Gangliosides are the main glycolipids of neuronal plasma membranes. Their surface
patterns are generated by coordinated processes, involving biosynthetic pathways of the …
patterns are generated by coordinated processes, involving biosynthetic pathways of the …
Progressive myoclonus epilepsies: specific causes and diagnosis.
SF Berkovic, F Andermann, S Carpenter… - The New England …, 1986 - psycnet.apa.org
Outlines the major features of the diseases known to cause progressive myoclonus epilepsy
and discusses a clinical approach to diagnosis. The 5 major conditions that account for the …
and discusses a clinical approach to diagnosis. The 5 major conditions that account for the …
Implications of normal brain development for the pathogenesis of schizophrenia
DR Weinberger - Archives of general psychiatry, 1987 - jamanetwork.com
• Recent research on schizophrenia has demonstrated that in this disorder the brain is not,
strictly speaking, normal. The findings suggest that nonspecific histopathology exists in the …
strictly speaking, normal. The findings suggest that nonspecific histopathology exists in the …
Neurology and the kidney
DJ Burn, D Bates - Journal of Neurology, Neurosurgery & Psychiatry, 1998 - jnnp.bmj.com
Renal failure is relatively common, but except in association with spina bifida or paraplegia it
is unlikely to occur as a result of disease of the CNS. Renal failure, however, commonly …
is unlikely to occur as a result of disease of the CNS. Renal failure, however, commonly …
[HTML][HTML] Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice
A Biffi, A Capotondo, S Fasano… - The Journal of …, 2006 - Am Soc Clin Investig
Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by deficiency
of the enzyme arylsulfatase A (ARSA). MLD is characterized by progressive demyelination …
of the enzyme arylsulfatase A (ARSA). MLD is characterized by progressive demyelination …
Clinical approach to inherited metabolic diseases
JM Saudubray, HO de Baulny… - Inborn metabolic diseases …, 1995 - Springer
Inborn errors of metabolism are individually rare, but collectively numerous. As a whole, they
cannot be recognized through systematic neonatal screening tests, which are too slow, too …
cannot be recognized through systematic neonatal screening tests, which are too slow, too …
Sanfilippo syndrome: Overall review
F Andrade, L Aldámiz‐Echevarría… - Pediatrics …, 2015 - Wiley Online Library
Abstract Mucopolysaccharidosis type III (MPS III, Sanfilippo syndrome) is a lysosomal
storage disorder, caused by a deficiency in one of the four enzymes involved in the …
storage disorder, caused by a deficiency in one of the four enzymes involved in the …
Repeated use of the emergency department: qualitative study of the patient's perspective
M Olsson, H Hansagi - Emergency Medicine Journal, 2001 - emj.bmj.com
Objective—To explore what lies behind repeated emergency department (ED) use, from the
patients' own perspectives. Methods—Qualitative study based on in depth interviews with …
patients' own perspectives. Methods—Qualitative study based on in depth interviews with …
Small fiber dysfunction predominates in Fabry neuropathy
M Dütsch, H Marthol, B Stemper, M Brys… - Journal of Clinical …, 2002 - journals.lww.com
Fabry disease is an X-linked recessive disease with a reduction of lysosomal α
galactosidase A and consecutive storage of glycolipids eg, in the brain, kidney, skin, and …
galactosidase A and consecutive storage of glycolipids eg, in the brain, kidney, skin, and …
Enzyme replacement therapy improves function of C-, Aδ-, and Aβ-nerve fibers in Fabry neuropathy
Background: Peripheral neuropathy in Fabry disease predominantly involves small nerve
fibers. Recently, enzyme replacement therapy (ERT) with recombinant human α …
fibers. Recently, enzyme replacement therapy (ERT) with recombinant human α …